Kristiina Vuori MD - 10 Sep 2024 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Role: Director
Signature: /s/ Kelly Deck, as attorney-in-fact to Kristiina Vuori
Issuer symbol: INBX
Transactions as of: 10 Sep 2024
Net transactions value: +$99,992
Form type: 4
Filing time: 12 Sep 2024, 17:14:23 UTC
Previous filing: 03 Sep 2024
Next filing: 07 Oct 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INBX	Common Stock	Purchase	$2,685	+179	+2.5%	$15.00	7,319	10 Sep 2024	Direct
transaction	INBX	Common Stock	Purchase	$97,307	+6,457	+88%	$15.07	13,776	11 Sep 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were purchased in multiple transactions at prices ranging from $15.00 to $15.08, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Content

The shares were purchased in multiple transactions at prices ranging from $15.00 to $15.08, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.